Use of insulin pumps in Denmark;Anvendelse af insulinpumper i Danmark

Ugeskrift for Laeger

Volumn 165, Issue 23, 2003, Pages 2380-2382

  Nørgaard, Kirsten ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DENMARK; DIABETES CONTROL; EQUIPMENT; EVALUATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; KIDNEY FUNCTION; META ANALYSIS; METABOLIC REGULATION; OUTCOMES RESEARCH; PATIENT MONITORING; TECHNIQUE; TREATMENT INDICATION; ADOLESCENT; ADULT; CHILD; FEMALE; INFUSION PUMP; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ADULT; CHILD; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS; INSULIN; MALE; QUESTIONNAIRES;

EID: 0042207083     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pickup JC, Keen H, Parsons JA et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1978;1:204-7.
2. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986;2:1300-4.
3. Feldt-Rasmussen B, Mathiesen ER, Jensen T et al. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991;3:164-70.
4. Dahl-Jorgensen K, Bjoro T, Kierulf P et al. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992;4: 920-3.
5. Jakobsen J, Christiansen JS, Kristoffersen I et al. Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes 1988;4:452-5.
6. Boulton AJM, Drury J, Clarke B. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982;5:386-390.
7. Kronert K, Hulser J, Luft D et al. Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction. J Clin Endocrinol Metab 1987;6:1219-23.
8. Lawson P, Trayner I, Rosenstock J et al. The effect of continuous subcutaneous insulin infusion on serum lipids. Diabete Metab 1984;4:239-44.
9. Beck-Nielsen H, Olesen T, Mogensen CE et al. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy retiropathy and renal involvement. Diabetes Res 1990;4:185-90.
10. Selam JL, Millet P, Zaluski S et al. Beneficial effect of glycaemic improvement in non-ischaemic forms of diabetic retinopathy: a 3-year follow-up. Diabet Med 1986;1:60-4.
11. Egger M, Davey Smith G, Stettler C et al. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997;14:919-28.
12. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of lorg-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
13. The DCCT Research Group. Implementation of treatment protocols in the DCCT. Diabetes Care 1995;18:361-76.
14. Pickup J. Keen H. Continuous subcutaneous insulin infusion in type 1 diabetes. BMJ 2001;322:1262-3.
15. Bode BW, Sabbah HT, Gross TM et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18(suppl 1):14-20.
16. Bode BW, Steed RD, Davidson P. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996;19:324-7.
17. Bode BW, Gross TM, Ghegan M et al. Breaking the age barrier: a comparison of continuous subcutaneous insulin infusion in adolescents and adults. Diabetologia 1999;42;227.
18. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705-8.
19. Renner R, Pfützner A, Trautmann M et al and the German humalog-CSII study Group. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care 1999;22:784-8.
20. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care 2002;25:593-8.